KANK3

KANK3 is an ankyrin-repeat, coiled-coil, and KN-motif domain protein implicated in actin cytoskeleton organization and the suppression of cancer cell migration, invasion, and proliferation (PMID:17996375, PMID:36463587). It is a substrate of the oxygen sensor HIF1AN (Factor Inhibiting HIF), which hydroxylates KANK3 at three asparagine residues within its ankyrin repeat domain, and its tumor-suppressive activity in migration and invasion is oxygen-dependent, being lost under hypoxic conditions (PMID:29047187). KANK3 restrains proliferation and metastatic behavior at least in part through activation of the p38 MAPK pathway, with overexpression elevating p-p38 levels and inhibiting cell growth (PMID:36463587). KANK3 is also a hypoxia-inducible, p53-dependent proapoptotic transcriptional target, requiring the DNA-binding and transactivation domains of p53 and placing it specifically in the hypoxia-p53 apoptotic axis rather than the DNA-damage response (PMID:25961455). Its zebrafish ortholog binds the Numb PTB domain via a conserved NGGY-containing region and acts at sites of cell-cell contact to regulate adhesion and tissue integrity during development (PMID:22387208).

1. 2007 Low

   Established KANK3 as a domain-conserved Kank family member with a candidate role in actin organization, the first functional hint for an otherwise uncharacterized protein.

   Evidence Overexpression in NIH3T3 cells with immunostaining for stress fibers

   PMID:17996375

   Open questions at the time

   • Single overexpression assay with no mutagenesis
   • No direct binding partner or mechanism linking KANK3 to actin remodeling
   • Endogenous function not addressed
2. 2012 Medium

   Identified a direct physical and genetic partner for the KANK3 ortholog, linking it to the Numb adaptor and cell-cell adhesion during development.

   Evidence Yeast two-hybrid, morpholino double-morphant epistasis, and localization in zebrafish

   PMID:22387208

   Open questions at the time

   • Demonstrated for the zebrafish ortholog NBP, not directly for human KANK3
   • Functional significance of the Numb interaction in mammalian cells unknown
   • No structural mapping beyond the NGGY region
3. 2015 Medium

   Placed KANK3 in a specific signaling context as a hypoxia-inducible, p53-dependent proapoptotic target distinct from the DNA-damage p53 program.

   Evidence RNA-seq under hypoxia across cell lines with p53 domain-mutant dissection and RT-PCR validation

   PMID:25961455

   Open questions at the time

   • KANK3-specific rescue of the apoptotic phenotype not demonstrated
   • Direct p53 binding to KANK3 promoter not mapped
   • Mechanism by which KANK3 promotes apoptosis unresolved
4. 2017 High

   Defined a biochemical oxygen-sensing mechanism by showing KANK3 is hydroxylated by HIF1AN at three ankyrin-domain asparagines, coupling its tumor-suppressive activity to oxygen availability.

   Evidence In vitro hydroxylation assay with MS site identification plus knockdown/overexpression migration-invasion assays under normoxia vs hypoxia in HCC cells

   PMID:29047187

   Open questions at the time

   • Functional consequence of each hydroxylation site not individually tested by mutagenesis
   • Downstream effector of hydroxylated KANK3 unknown
   • Link between hydroxylation and the p38 or p53 pathways unexplored
5. 2020 Low

   Refined KANK3 expression to vascular and lymphatic endothelial cells, distinguishing it from other Kank members and hinting at a cell-type-restricted role.

   Evidence Immunostaining and mRNA analysis across mouse tissues

   PMID:33253712

   Open questions at the time

   • Localization only, no functional consequence demonstrated
   • Endothelial-specific function untested
   • Relationship to its tumor cell roles unclear
6. 2022 Medium

   Connected KANK3's anti-tumor activity to a defined signaling axis by showing it suppresses lung adenocarcinoma proliferation, invasion, and migration via p38 MAPK.

   Evidence siRNA/overexpression with proliferation, Transwell, wound-healing assays and p-p38 Western blot in NCI-H1975 and PC-9 cells

   PMID:36463587

   Open questions at the time

   • No rescue or mutagenesis to confirm p38 dependence
   • Mechanism by which KANK3 activates p38 not defined
   • Relationship to HIF1AN hydroxylation and p53 induction not integrated

• How the oxygen-dependent HIF1AN hydroxylation, p53-dependent induction, and p38 MAPK signaling integrate into a single coherent KANK3 mechanism remains unresolved.
• No unifying model linking hydroxylation, transcriptional induction, and p38 output
• No structural model of the ankyrin domain bound to HIF1AN or Numb in human cells
• Endothelial versus tumor-cell function not reconciled